Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$334.10M
Total Bought:
$0
Total Sold:
$74.9K
Net Transaction:
-$74.9K
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830$118.44M$136.40M40.83%+$17.95M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$45.03M$43.90M13.14%-$1.13M
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,0510$25.06M$28.55M8.55%+$3.50M
Legend Biotech CorporationADS(LEGN)814,586814,5860$27.64M$28.21M8.44%+$570.2K
Nanobiotix S.A.ADS(NBTX)5,623,8165,623,8160$20.13M$25.45M7.62%+$5.32M
CVRx, Inc.(CVRX)4,103,4304,103,4300$50.18M$23.88M7.15%-$26.30M
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$20.85M$20.37M6.10%-$483.2K
Contineum Therapeutics, Inc.CL A(CTNM)1,979,1731,979,1730$13.81M$8.13M2.43%-$5.68M
Xencor, Inc.(XNCR)748,062748,0620$7.96M$6.09M1.82%-$1.87M
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$3.15M$3.98M1.19%+$827.0K
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$2.67M$3.51M1.05%+$844.4K
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,4450$1.85M$1.40M0.42%-$449.6K
Rallybio Corporation(RLYB)3,636,3633,636,3630$2.38M$1.21M0.36%-$1.17M
Vor Biopharma Inc.(VOR)1,074,6581,074,6580$771.1K$1.14M0.34%+$368.1K
Nano-X Imaging Ltd.
ORD SHS
158,852158,8520$793.5K$830.8K0.25%+$37.3K
Standard BioTools Inc.(LAB)311,967311,9670$336.9K$371.2K0.11%+$34.3K
Lyell Immunopharma, Inc.(LYEL)823,31741,165-782,152$442.9K$368.0K0.11%-$74.9K
Adicet Bio, Inc.364,472364,4720$275.2K$228.0K0.07%-$47.2K
Tessera Defense and Homeland Security Inc.(HLSQ)96,86696,8660$53.8K$42.6K0.01%-$11.2K
Senseonics Holdings, Inc.(SENS)54,62154,6210$35.8K$27.0K0.01%-$8.8K
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q2 2025 | TickerTrail